Internal Medicine, Nephrology · Lancaster, CA
NPI
1962732974
Since 2010
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1759 W Avenue J, Suite 101
Lancaster, CA, 93534
Phone (661) 948-1388
Groups this clinician bills Medicare through
Medicare paid, 2024
$123K
1,152 services
Medicare patients, 2024
246
Average age 68
Drug cost, 2024
$533K
1,762 prescriptions
Company payments, 2025
$318
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nanette C Fonte was code 99232 (hospital e&m - subsequent), 548 times for 96 patients. In total Nanette C Fonte billed 1,152 services in 17 codes, and Medicare paid $123K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-08-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 548 | 96 | $64.76 | $35K |
| 99223 Hospital E&M - Initial | Facility | 164 | 116 | $139.70 | $23K |
| 99214 Office E&M - Established | Office | 127 | 62 | $76.96 | $9,774 |
| 99233 Hospital E&M - Subsequent | Facility | 117 | 37 | $97.05 | $11K |
| 90960 ESRD Related Services (not dialysis) | Office | 81 | 52 | $294.93 | $24K |
| 90961 ESRD Related Services (not dialysis) | Office | 35 | 28 | $245.35 | $8,587 |
| 99205 Office E&M - New | Office | 13 | 13 | $168.60 | $2,192 |
By year: 2022 $80K for 957 services; 2023 $66K for 837 services; 2024 $123K for 1,152 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nanette C Fonte prescribed most often to Medicare patients was Amlodipine Besylate, with 124 prescriptions and refills. In total Nanette C Fonte wrote 1,762 Medicare prescriptions that cost $533K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 124 | 291 | 46 | $505 |
| Calcium Acetate Generic | 123 | 296 | 58 | $20K |
| Prosol Parenteral Amino Acid 20% No.1 | 105 | 105 | Under 11 | $17K |
| Sevelamer Carbonate Generic | 94 | 204 | 39 | $23K |
| Losartan Potassium Generic | 89 | 245 | 33 | $803 |
| Furosemide Generic | 80 | 211 | 30 | $549 |
| Carvedilol Generic | 78 | 199 | 29 | $426 |
| Hydralazine Hcl Generic | 75 | 190 | 34 | $1,105 |
| Calcitriol Generic | 49 | 123 | 14 | $1,169 |
| Nifedipine Er Nifedipine | 47 | 120 | 23 | $2,698 |
| Clonidine Hcl Generic | 44 | 124 | 20 | $489 |
| Lokelma Sodium Zirconium Cyclosilicate | 39 | 56 | 24 | $34K |
| Clinisol Parenteral Amino Acid 15% No.5 | 39 | 39 | Under 11 | $6,972 |
| Atorvastatin Calcium Generic | 39 | 113 | 15 | $181 |
| Potassium Chloride Generic | 36 | 52 | 11 | $362 |
Brand drugs: - claims; generic drugs: 1,430 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nanette C Fonte $318 ($318 in general payments such as food, travel and fees) from 9 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $71.07.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 3 | $71.07 |
| Akebia Therapeutics Inc AKBA | 2 | $55.71 |
| Calliditas Therapeutics US Inc. | 2 | $39.21 |
| Amgen Inc. AMGN | 1 | $29.2 |
| CorMedix Inc. CRMD | 1 | $28.21 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $25.2 |
| GlaxoSmithKline, LLC. GSK | 1 | $24.19 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $23.55 |
| Mallinckrodt Hospital Products Inc. | 1 | $21.69 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.